You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Remote Brief Intervention and Referral to Treatment Service for Alcohol (R-BIRT)
SBC: POLARIS HEALTH DIRECTIONS, INC Topic: NIAAADESCRIPTIONprovided by applicantSignificanceThe USPHSTFSAMHSACDCand NIAAA have affirmed the importance of screening in medical settings for alcohol consumption that exceeds the NIAAA low risk limitsbrief educational and motivational counseling for those who screen positive or have other evidence of an Alcohol Use Disorderandwhen appropriatereferral to treatmentSBIRTHowevertranslation to clinical p ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Polaris Oncology Survivor Transition POST System
SBC: POLARIS HEALTH DIRECTIONS, INC Topic: 100DESCRIPTION provided by applicant By January oncology care providers will be expected to craft Survivorship Care Plans SCPs for all individuals ending active treatment for cancer however there is a lack of systematic study of the impact survivorship planning has on patients providers or healthcare systems The Polaris Oncology Survivorship Transition POST program is a web based sy ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Clinical Trial of ABC in Patients with Refractory Multiple Myeloma
SBC: Apogee Biotechnology Corporation Topic: NCIDESCRIPTION provided by applicant Multiple myeloma MM is the second most common hematological malignancy in the United States and remains an incurable disease since nearly all MM patients will eventually relapse and develop resistance to currently available drugs Sphingolipid metabolism is being increasingly recognized as a key pathway in tumor biology In particular sphingosine kinases S ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors
SBC: KEYSTONE NANO, INC. Topic: 102DESCRIPTIONprovided by applicantKeystone Nanoin partnership with the University of Maryland Greenebaum Cancer CenterUMD GCCproposes a multi site clinical evaluation of the Ceramide NanoLiposomeCNLas a novel anti cancer therapeuticThe overall objective of this project is to advance the CNL through a Phase I clinical trialThe results of this trial will support subsequent trials for the intended init ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
TissueCypher Testing for Risk Assessment in Barretts Esophagus
SBC: Cernostics Inc Topic: 102DESCRIPTION provided by applicant Barrettandapos s esophagus is a pre neoplastic disease that predisposes patients to development of esophageal adenocarcinoma EAC Approximately million people in the US have Barrettandapos s esophagus and they are frequently screened by endoscopy with pathological analyses of esophageal biopsies The goal of the screening is to detect premalignant changes e ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
SBC: ImCare Biotech LLC Topic: NCIDESCRIPTIONprovided by applicantHepatocellular carcinomaHCCis usually undetected until its later stageswhere theyear survival rate for patients is less thanHoweverthe survival rate can be as high asif the cancer is detected earlyUnfortunatelyearly detection of HCC is not possible with any screening tests that are currently availablesuch as ultrasound or imaging technologiesAlpha FetoproteinAFPwhic ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Development of Small Molecule Therapeutics Against Smallpox and Other Poxviruses
SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC. Topic: RDESCRIPTION provided by applicant The smallpox virus variola has been responsible for the deaths of hundreds of millions of people worldwide Although smallpox was eradicated from the globe in following a valiant immunization campaign existing viral stocks may fall into the hands of those seeking to employ variola as a biological weapon This calls for the development of safe antiviral ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
CATHEPSIN L INHIBITORS AS PAN CORONAVIRUS THERAPEUTICS
SBC: PHELIX THERAPEUTICS LLC Topic: RDESCRIPTION provided by applicant Coronaviruses CoV are RNA viruses that cause gastrointestinal respiratory and neurological symptoms in several mammalian species The outbreak of the severe acute respiratory syndrome CoV SARS CoV in humans was fatal in of infected patients infecting people and killing The recent incidents involving the highly pathogenic Middle East ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Non Spherical Particles for HPLC
SBC: ADVANCED MATERIALS TECHNOLOGY, INC. Topic: 100DESCRIPTION provided by applicant Extending liquid chromatographic column technology to even higher performance levels has given rise to ultra high pressure liquid chromatography UPLC core shell particle technology and instrumental developments such as lower volumes for injector and detector hydraulics In spite of these advances there is still room for improvement in speed selectivity and ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Development and Deployment of the Movable Type Method for Drug Discovery and Desi
SBC: QUANTUMBIO INC Topic: 300DESCRIPTION provided by applicant Our long term goal is to provide a solution to the protein ligand binding affinity and pose prediction problems The protein ligand docking and scoring problem is one of the central problems in computational biology because of its importance in understanding intermolecular interactions and because of its practical payoff The transformative impact molecular do ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health